Endovascular Modalites for Contralateral Common Iliac Artery in Patients With Symptomatic Unilateral Common Iliac Artery Occlusive Disease
1 other identifier
observational
50
0 countries
N/A
Brief Summary
To evaluate the safety, efficacy, and outcomes of endovascular strategies for protection of the contralateral CIA in patients with symptomatic unilateral CIA occlusive disease
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 1, 2025
CompletedFirst Posted
Study publicly available on registry
June 10, 2025
CompletedStudy Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
June 10, 2025
June 1, 2025
1.4 years
June 1, 2025
June 1, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Primary patency of both common iliac arteries
2 years
Interventions
Stenting of common iliac artery by balloon mounted stent
Eligibility Criteria
Patients attending the Vascular Surgery Clinics in Assiut University Hospitals complaining of unilateral CIA ostial occlusive disease, Rutherford category 3, 4and 5 will be recruited to participate in the study.
You may qualify if:
- Symptomatic patients (Rutherford category 3- 5) due to Unilateral common iliac artery occlusive disease.
- with or without combined iliac or femoropopliteal or infrapopliteal lesions.
- Asymptomatic Contralateral limb.
- Patent at least one run-off vessel
You may not qualify if:
- Distal aorta lesion
- contralateral CIA occlusion
- Previous endovascular or surgical procedures for the same lesion
- Hypersensitivity to contrast material
- Presence of aortic or iliac aneurysms
- Patients with unsalvageable limb
- Non atherosclerotic lesions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Aboyans V, Desormais I, Lacroix P, Salazar J, Criqui MH, Laskar M. The general prognosis of patients with peripheral arterial disease differs according to the disease localization. J Am Coll Cardiol. 2010 Mar 2;55(9):898-903. doi: 10.1016/j.jacc.2009.09.055.
PMID: 20185041BACKGROUND
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant lecturer
Study Record Dates
First Submitted
June 1, 2025
First Posted
June 10, 2025
Study Start
August 1, 2025
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
May 1, 2027
Last Updated
June 10, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share